financetom
Business
financetom
/
Business
/
Reinsurer RenaissanceRe's Q3 net income drops to $907.7 mln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reinsurer RenaissanceRe's Q3 net income drops to $907.7 mln
Oct 28, 2025 1:50 PM

Overview

* RenaissanceRe's ( RNR/PF ) Q3 net income falls to $907.7 mln from $1.17 bln, while operating income rises

* Company achieves combined ratio of 68.4%, reflecting improved underwriting performance

* Fee income rises 24.1% yr/yr, driven by positive underwriting results

Outlook

* RenaissanceRe ( RNR/PF ) did not provide specific financial guidance for future quarters or the full year

Result Drivers

* CATASTROPHE PREMIUM GROWTH - 21.9% underlying growth in catastrophe class gross premiums written, primarily in U.S. catastrophe-exposed business

* LOW CATASTROPHE LOSSES - Improved net claims and claim expense ratio due to low catastrophe losses in Q3 2025

* INCREASED FEE INCOME - Fee income up 24.1% from Q3 2024, driven by positive underwriting results and favorable development in DaVinci

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Gross $2.32

Premiums bln

Q3 68.40%

Combined

Ratio

Q3 Fee $101.80

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the reinsurance peer group is "buy."

* Wall Street's median 12-month price target for Renaissancere Holdings Ltd ( RNR/PF ) is $278.00, about 12.9% above its October 27 closing price of $242.27

* The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Discount retailer Five Below Q2 sales beat estimates
Discount retailer Five Below Q2 sales beat estimates
Aug 27, 2025
Overview * Five Below ( FIVE ) Q2 sales rise 23.7% to $1.03 bln, beating estimates * Adjusted EPS for Q2 at $0.81, reflecting strong performance * Co raises full-year 2025 sales and EPS guidance Outlook * Five Below ( FIVE ) expects Q3 net sales of $950 mln to $970 mln * Company anticipates Q3 net income between $5...
Apparel retailer Urban Outfitters Q2 sales beat estimates
Apparel retailer Urban Outfitters Q2 sales beat estimates
Aug 27, 2025
Overview * Urban Outfitters ( URBN ) Q2 net sales rise 11.3% to $1.50 bln, beating estimates * Record net income of $143.9 mln reported for Q2, EPS at $1.58 * Subscription segment sales surge 53.2%, boosting overall revenue growth Result Drivers * RETAIL SALES GROWTH - Driven by mid single-digit positive growth in both retail store and digital channel...
Greif Q3 revenue misses estimates
Greif Q3 revenue misses estimates
Aug 27, 2025
Overview * Greif ( GEF ) fiscal Q3 revenue missed analyst expectations, per LSEG data * Adjusted EBITDA for fiscal Q3 increased 11% yr/yr * Co divesting containerboard business for $1.8 bln, sale closes Aug 31 Outlook * Greif ( GEF ) expects fiscal 2025 Combined Adjusted EBITDA $725 - $735 mln * Company anticipates adjusted free cash flow of...
CVS Health Clocks $12.25 Million Settlement on Claims of Overcharging MassHealth
CVS Health Clocks $12.25 Million Settlement on Claims of Overcharging MassHealth
Aug 27, 2025
04:12 PM EDT, 08/27/2025 (MT Newswires) -- CVS Health ( CVS ) has reached a $12.25 million settlement with the Massachusetts Attorney General's Office, over allegations that the pharma company overcharged the state's Medicaid program, MassHealth, for prescription drugs, the Office of Attorney said Wednesday. As per the settlement, the company, apart from the fee, will now also implement an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved